Novo Nordisk
NVO
#19
Rank
C$671.38 B
Marketcap
$147.90
Share price
-1.49%
Change (1 day)
8.83%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of September 2024 : C$11.98 Billion

According to Novo Nordisk's latest financial reports the company's total debt is C$11.98 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$5.30 B5.29%
2022-12-31C$5.03 B-2.54%
2021-12-31C$5.16 B136.86%
2020-12-31C$2.18 B148.64%
2019-12-31C$0.87 B716.75%
2018-12-31C$0.10 B-68.7%
2017-12-31C$0.34 B687.98%
2016-12-31C$43.57 M-80.02%
2015-12-31C$0.21 B59.84%
2014-12-31C$0.13 B222.06%
2013-12-31C$42.37 M-51.94%
2012-12-31C$88.16 M-41.68%
2011-12-31C$0.15 B-61.9%
2010-12-31C$0.39 B41.02%
2009-12-31C$0.28 B-46.92%
2008-12-31C$0.53 B98.84%
2007-12-31C$0.26 B-14.73%
2006-12-31C$0.31 B-37%
2005-12-31C$0.49 B32.97%
2004-12-31C$0.37 B-1.82%
2003-12-31C$0.38 B20.66%
2002-12-31C$0.31 B-18.5%
2001-12-31C$0.38 B1.68%
2000-12-31C$0.38 B-8.51%
1999-12-31C$0.41 B-31.85%
1998-12-31C$0.60 B-4.37%
1997-12-31C$0.63 B40.89%
1996-12-31C$0.45 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$93.55 B 680.55%๐Ÿ‡บ๐Ÿ‡ธ USA
C$43.70 B 264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$72.18 B 502.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$35.75 B 198.32%๐Ÿ‡ซ๐Ÿ‡ท France